|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
sanofi- aventis Pharma Slovakia s.r.o.
Main Activities: Professional, Scientific, and Technical Services
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name sanofi- aventis Pharma Slovakia s.r.o. Headquarters Einsteinova 24; Bratislava ; Bratislavsky; 851 01 |
Status: Non-Listed Legal Form: Limited Liability Company Operational Status: Operational SK-ICO: 35686049 |
|
Company Description |
| Sanofi-aventis is one of the pharmaceutical companies in the world, headquartered in Paris and with a directorate of Slovakia in Bratislava. The portfolio of products sold by sanofi-aventis are several medicines for the treatment of thrombosis, cardiovascular disease, sleep disorders, epilepsy, diabetes and cancer. |
Company Analysis |
 For the latest financial data available click here.The company sanofi- aventis Pharma Slovakia s.r.o. posted in 2008 in accordance with the Local Accounting Standards a non-consolidated profit of SKK 9.49 mn. Compared with the previous period, when profit amounted to SKK 8.88 mn, it showed a 6.8% increase. Revenues within the observed period reached SKK 504.15 mn, while in the previous year it amounted to SKK 493.11 mn, which is 2.24% more. At the end of the year, total assets were reported at SKK 156.34 mn, return on assets (ROA) reached 6.07%, return on equity (ROE) 12.1% and return on sales (ROS) 1.89%. |
Key Executives |
|
|||||
|
|||||
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
| SELECT CURRENCY |
| Figures in: EUR | USD |
|
2010 Y (non-cons) |
2009 Y (non-cons) |
|
 | ||
| Audited | Audited | |
| ||
| ISI Company Financials | ISI Company Financials | |
| ||
| Unit | 1 | 1 |
| ||
Balance Sheet
| ||
Total Assets |
7,734,667 |
6,814,763 |
| ||
Current Assets |
X,XXX,XXX |
X,XXX,XXX |
| ||
Total Liabilities |
X,XXX,XXX |
X,XXX,XXX |
| ||
Shareholders Equity |
X,XXX,XXX |
X,XXX,XXX |
| ||
Current Liabilities |
X,XXX,XXX |
X,XXX,XXX |
| ||
| * All the accounts are in EUR. | ||
Income Statement
| ||
Total Operating Revenue |
XX,XXX,XXX |
XX,XXX,XXX |
| ||
Operational Profit (Loss) |
XXX,XXX |
XXX,XXX |
| ||
Net Profit (Loss) |
XXX,XXX |
XXX,XXX |
| ||
| * All the accounts are in EUR. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
X.XX% |
X.XX% |
| ||
Annualised Return on Assets (ROA) |
X.XX% |
X.XX% |
| ||
Return on Equity (ROE) |
XX.XX% |
XX.XX% |
| ||
Annualised Return on Equity (ROE) |
XX.XX% |
XX.XX% |
| ||
Return on Sales (ROS) |
X.XX% |
X.XX% |
| ||
Return on Capital |
XX.X% |
XX.XX% |
| ||
Gross Profit Margin |
XX.XX% |
XX.XX% |
| ||
Operating Profit Margin |
X.XX% |
X.X% |
| Efficiency Ratios | ||
| ||
Accounts Receivable Turnover |
X.XXx |
X.XXx |
| ||
Current asset turnover |
X.XXx |
X.XXx |
| ||
Fixed-asset turnover |
XX.XXx |
XX.XXx |
| ||
Asset Turnover |
X.XXx |
X.XXx |
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
XXX,XXX |
XXX,XXX |
| ||
EBITDA |
XXX,XXX |
X,XXX,XXX |
| ||
Bookvalue (BV) |
X,XXX,XXX |
X,XXX,XXX |
| ||
Net Cash |
-X,XXX,XXX |
-X,XXX,XXX |
| Liquidity Ratios | ||
| ||
Current Ratio |
XXX.XX% |
XXX.XX% |
| ||
Quick ratio |
XXX.XX% |
XXX.XX% |
| ||
Doom's day ratio |
X.XX% |
XX.XX% |
| Leverage Ratios | ||
| ||
Leverage ratio |
XXX.XX% |
XXX.XX% |
| ||
Interest Coverage Ratio |
XX,XXX,XXX% |
X,XXX,XXX.XX% |
| ||
Debt to equity |
XXX.XX% |
XX% |
| ||
Debt to total assets |
XX.XX% |
XX.X% |
| ||
Long Term Debt to Capital |
X.XX% |
X.XX% |
| Trend Ratios | ||
| ||
Revenue Trend |
XX.XX% |
|
| ||
Net Income Trend |
XX.XX% |
|
| ||
Operating Income Trend |
XX.XX% |
|
| ||
 |